Bio-GHK Incorporated Collagen Film Raises Wound-Site Copper Ninefold, Accelerating Dermal Repair in Rats
Background
Dermal wound healing remains a significant clinical challenge when sustained delivery of bioactive agents to the wound site is difficult to achieve. Matrikines — small peptide fragments derived from extracellular matrix (ECM) proteins — possess potent tissue-repair activities but their therapeutic utility is constrained by poor localized retention. GHK (glycyl-histidyl-lysine) is a well-characterised matrikine with known roles in collagen synthesis, antioxidant defense, and copper transport. Current wound-care biomaterials lack reliable mechanisms for prolonged, high-concentration peptide presentation at the wound bed, leaving a gap between the known biology of GHK and effective clinical delivery.
Study Design
A rat dermal wound model was used to compare three treatment groups: biotinylated GHK (Bio-GHK) incorporated collagen film (PIC), plain collagen film (CF), and untreated control (CR). Binding affinity of Bio-GHK versus Boc-GHK (t-butyloxycarbonyl-substituted GHK) to the collagen matrix and red blood cell membranes was assessed. Primary endpoints included wound contraction, cell proliferation, antioxidant enzyme expression, and wound-site copper concentration. A ninefold copper elevation served as a key mechanistic readout distinguishing the biotinylated formulation.
Results
PIC-treated wounds demonstrated superior wound contraction and increased cell proliferation relative to both CF and CR groups. Bio-GHK showed stronger binding to the collagen matrix and RBC membranes compared with Boc-GHK, supporting its improved retention at the wound site. Antioxidant enzyme expression was elevated in the PIC group, suggesting a protective oxidative microenvironment conducive to repair. Mechanistically, Bio-GHK incorporation into collagen was associated with local copper trafficking, consistent with GHK's known role as a copper-binding peptide.
Bio-GHK incorporated collagen increased copper concentration by ninefold at the wound site compared to controls, linking its healing activity to both copper localization and matrikine signaling.
Key Findings
- Bio-GHK incorporated collagen (PIC) outperformed both plain collagen film and untreated control for wound healing
- Wound-site copper concentration increased ninefold in the PIC group compared to controls
- Bio-GHK bound collagen matrix and RBC membranes more effectively than Boc-GHK
- PIC group showed increased cell proliferation and higher antioxidant enzyme expression
- Results support both copper localization and matrikine activity as dual mechanisms of Bio-GHK wound repair
Why It Matters
Biotinylation as a collagen-anchoring strategy offers a practical route to extend GHK residence time at wound sites — a longstanding barrier to translating this peptide's well-documented biology into effective topical therapeutics. The ninefold copper enrichment is particularly significant because copper is a cofactor for lysyl oxidase and other enzymes critical to collagen cross-linking and angiogenesis, implying the biomaterial may amplify multiple repair pathways simultaneously. For clinicians and formulators, combining GHK with a biotinylated collagen scaffold may represent a more effective delivery paradigm than topical GHK-Cu solutions alone. Translation still requires human trials, scale-up of the PIC fabrication process, and safety characterization of biotinylated constructs in vivo over longer timeframes.
